Cite
HARVARD Citation
Afolabi, S. et al. (2021). Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorate the Effect of Combined Oral Contraceptive- (COC-) Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats. International journal of reproductive medicine. p. . [Online].